Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session

Author: Lisa Levin | December 19, 2022 02:38pm

Gainers

  • Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
  • Axcella Health Inc. (NASDAQ:AXLA) shares rose 153% to $0.4105. Axcella Health shares dipped 63% on Friday after SVB Leerink downgraded the stock from Outperform to Market Perform and lowered its price target from $6 to $2.
  • Camber Energy, Inc. (NYSE:CEI) shares climbed 103% to $0.1257 after the company announced an anticipated effective date of December 21, 2022 for its previously-announced 1-for-50 reverse stock split.
  • Qumu Corporation (NASDAQ:QUMU) gained 98.2% to $0.8722 after Enghouse Systems announced it will acquire the company for $0.90 per share in cash.
  • AirNet Technology Inc. (NASDAQ:ANTE) jumped 64% to $1.93.
  • Viking Therapeutics, Inc. (NASDAQ:VKTX) shares climbed 61% to $6.48 in sympathy with Madrigal Pharmaceuticals which announced a successful trial for liver fibrosis.
  • Nogin, Inc. (NASDAQ:NOGN) rose 44% to $0.72 after declining 39% on Friday. Nogin’s Co-CEO and President Jonathan Huberman recently acquired a total of 19,300 shares at an average price of $0.90.
  • Soleno Therapeutics, Inc. (NASDAQ:SLNO) surged 39% to $1.26 after the company announced a financing commitment for up to $60 million.
  • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) rose 39% to $9.55 in sympathy with Madrigal Pharmaceuticals, which gained after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
  • Caravelle International Group (NASDAQ:CACO) gained 38.8% to $5.83.
  • Agrify Corporation (NASDAQ:AGFY) climbed 38% to $0.3410 after dipping around 70% on Friday. Agrify announced pricing of a public offering.
  • Innate Pharma S.A. (NASDAQ:IPHA) rose 37% to $2.6032 after the company and Sanofi announced an expansion of their collaboration for natural killer cell therapeutics in oncology. Innate will receive a €25 million upfront payment.
  • Greenidge Generation Holdings Inc. (NASDAQ:GREE) rose 30.3% to $0.3260 after dropping 39% on Friday.
  • Cazoo Group Ltd (NYSE:CZOO) rose 24.4% to $0.1618. Cazoo recently sold its Spanish subscription business, Swipcar, to Renting Finders S.L.
  • Otonomy, Inc. (NASDAQ:OTIC) rose 24.1% to $0.1118 after dropping over 21% on Friday.
  • Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) gained 24% to $31.53 after the company said its Emraclidine Ambulatory Blood Pressuring Monitoring Trial did not cause an increase in blood pressure.
  • Aspen Group, Inc. (NASDAQ:ASPU) gained 23.3% to $0.2833. Aspen Group recently reported better-than-expected Q2 sales results.
  • iHuman Inc. (NYSE:IH) gained 21.2% to $2.80.
  • Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) gained 20.3% to $2.84.
  • Future FinTech Group Inc. (NASDAQ:FTFT) jumped 19.1% to $0.5480.
  • Celcuity Inc. (NASDAQ:CELC) gained 19% to $11.91.
  • AppHarvest, Inc. (NASDAQ:APPH) rose 18.7% to $0.5563.
  • Troika Media Group, Inc. (NASDAQ:TRKA) rose 17.8% to $0.1178 after dropping around 6% on Friday.
  • Bird Global, Inc. (NYSE:BRDS) gained 17.7% to $0.1765.
  • Professional Diversity Network, Inc. (NASDAQ:IPDN) surged 17.6% to $0.7771.
  • Argo Blockchain plc (NASDAQ:ARBK) rose 17.5% to $0.45 after declining 21% on Friday.
  • Horizon Global Corporation (NYSE:HZN) gained 16.7% to $0.70.
  • PainReform Ltd. (NASDAQ:PRFX) gained 14% to $0.57.
  • Akili, Inc. (NASDAQ:AKLI) shares rose 14% to $1.14 after dipping 35% on Friday.
  • CI&T Inc (NYSE:CINT) gained 12.8% to $5.89. CI&T said that it has become an Amazon Web Services (AWS) Advanced Tier Services Partner within the AWS Partner Network.
  • Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) rose 11.6% to $1.15 after dropping 36% on Friday.
  • Reading International, Inc. (NASDAQ:RDIB) gained 10.2% to $19.77.
  • 17 Education & Technology Group Inc. (NASDAQ:YQ) rose 10.2% to $1.8286 after jumping 29% on Friday. 17 Education & Technology recently posted a Q3 loss of $0.01 per share.
  • Summit Therapeutics Inc. (NASDAQ:SMMT) gained 10% to $3.9699.
  • Perfect Corp. (NYSE:PERF) gained 8.4% to $7.10.
  • ObsEva SA (NASDAQ:OBSV) rose 6.6% to $0.1472. The company reported dismissal of moratorium proceedings.


Losers

  • Cosmos Health Inc. (NASDAQ:COSM) shares dipped 59.6% to $9.30 after the company reported pricing of $32.5 million registered direct offering and concurrent private placement priced at-the-market.
  • Forward Pharma A/S (NASDAQ:FWP) fell 38.7% to $1.60. Forward Pharma announced expected delisting of its American Depositary Shares from the Nasdaq Capital Market.
  • Scopus BioPharma Inc. (NASDAQ:SCPS) fell 34.7% to $0.0556.
  • NantHealth, Inc. (NASDAQ:NH) fell 30.7% to $3.95. NantHealth recently announced a 1-for-15 reverse stock split.
  • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) dropped 25.1% to $2.4109.
  • VistaGen Therapeutics, Inc. (NASDAQ:VTGN) declined 25% to $0.1092. VistaGen Therapeutics recently announced the FDA granted Fast Track designation for the development of PH10 for the treatment of major depressive disorder.
  • Invacare Corporation (NYSE:IVC) dropped 25% to $0.4499.
  • Healthcare Triangle, Inc. (NASDAQ:HCTI) fell 23.7% to $0.2364.
  • Lanvin Group Holdings Limited (NYSE:LANV) fell 23% to $7.70 after surging 31% on Friday.
  • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) dropped 22.8% to $0.27. Neptune Wellness Solutions reported a net loss of $37.3 million for the fiscal second quarter 2023 versus a year-ago net loss of $12.1 million. Its net sales revenue declined to $12 million from $12.5 million.
  • PLDT Inc. (NYSE:PHI) dropped 22.4% to $20.81.
  • BiomX Inc. (NYSE:PHGE) shares fell 22.1% to $0.1720 after jumping 63% on Friday. BiomX, last month, posted a Q3 loss of $0.23 per share.
  • Tellurian Inc. (NASDAQ:TELL) dropped 20.3% to $1.93.
  • Gossamer Bio, Inc. (NASDAQ:GOSS) declined 20.3% to $2.1750.
  • Akero Therapeutics, Inc. (NASDAQ:AKRO) fell 18.9% to $38.10.
  • Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) fell 18.8% to $12.45. STAT News reporter Adam Feuerstein tweets "Intercept Pharmaceuticals Down 10% Because OCA's Future In NASH Looks Bleaker. Investors Really Want Intercept To Ditch NASH And Focus On The Approved PBC Indication."
  • TMC the metals company Inc. (NASDAQ:TMC) dropped 17.9% to $0.5598.
  • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) fell 17.8% to $9.28.
  • Nexa Resources S.A. (NYSE:NEXA) dropped 17.8% to $5.51.
  • Altimmune, Inc. (NASDAQ:ALT) fell 17.2% to $9.51.
  • 89bio, Inc. (NASDAQ:ETNB) fell 16.8% to $8.78.
  • Vivani Medical, Inc. (NASDAQ:VANI) dropped 16.7% to $0.8578.
  • Minim, Inc. (NASDAQ:MINM) fell 16.5% to $0.1773 after jumping 22% on Friday.
  • Carvana Co. (NYSE:CVNA) dropped 15.7% to $4.24.
  • Synaptogenix, Inc. (NASDAQ:SNPX) fell 14.3% to $1.0228. Synaptogenix shares dropped 75% on Friday after the company announced results from its Phase 2 clinical trial of Bryostatin-1 for the treatment of advanced Alzheimer's disease, in which the primary endpoint was not met with statistical significance.
  • Cue Health Inc. (NASDAQ:HLTH) fell 14.2% to $2.5050.
  • C4 Therapeutics, Inc. (NASDAQ:CCCC) dropped 14.1% to $6.32.
  • Seer, Inc. (NASDAQ:SEER) declined 13.6% to $5.40.
  • New Pacific Metals Corp. (NYSE:NEWP) fell 13.4% to $2.50.
  • Mondee Holdings, Inc. (NASDAQ:MOND) dropped 13.4% to $10.61.
  • Arcellx, Inc. (NASDAQ:ACLX) fell 12.2% to $27.97.
  • Richardson Electronics, Ltd. (NASDAQ:RELL) dropped 11.6% to $21.66.
  • Gevo, Inc. (NASDAQ:GEVO) fell 10.7% to $1.7950.
  • Cinemark Holdings, Inc. (NYSE:CNK) fell 10.5% to $9.69.
  • Domo, Inc. (NASDAQ:DOMO) dropped 10.5% to $14.81. Morgan Stanley maintained Domo with an Overweight and lowered the price target from $51 to $24.
  • Mersana Therapeutics, Inc. (NASDAQ:MRSN) dipped 10.5% to $5.82.
  • ChargePoint Holdings, Inc. (NYSE:CHPT) declined 9.6% to $9.45.
  • MasterBrand, Inc. (NYSE:MBC) fell 9.5% to $8.42 after jumping over 20% on Friday.
  • Relay Therapeutics, Inc. (NASDAQ:RLAY) dropped 9.4% to $15.44.
  • Melco Resorts & Entertainment Limited (NASDAQ:MLCO) fell 9.3% to $10.90.
  • AMC Entertainment Holdings, Inc. (NYSE:AMC) dropped 8.3% to $4.8650. AMC Entertainment announced Monday that it has raised $162 million from its AMC Preferred Equity Units since launching the stock just a few months ago.
  • Ardelyx, Inc (NASDAQ:ARDX) fell 7.9% to $1.8050 after the company provided an update regarding the appeal to the Complete Response Letter for the New Drug Application for XPHOZAH.
  • Mullen Automotive, Inc. (NASDAQ:MULN) fell 7.8% to $0.2787. Mullen Automotive recently announced it received a purchase order from Randy Marion Automotive Group for 6,000 Class 1 EV cargo vans.

Also check this out Over $13 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying.

Posted In: ACLX AGFY AKLI AKRO ALT AMC ANEB ANTE APPH ARBK ARDX ASPU AXLA BRDS CCCC CEI CELC CERE CHPT CINT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist